IP Library Patent Application 13050523
Patent Application
App. No. 13/050,523

ORAL SUPPLEMENT

Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US None
App. No.
13/050,523
Abstract

An oral supplement containing bilberry extract, quercetin, beta-carotene, co-enzyme Q-10, lipoic acid, vitamins, and minerals, which supports skin health, as well as a method of administering the same, alone and in conjunction with a topical skin care composition, is disclosed.

Claims (27)

1 . An oral supplement comprising:

a) bilberry extract,

b) quercetin,

c) beta-carotene,

d) co-enzyme Q-10,

e) lipoic acid,

f) vitamin A,

g) vitamin B,

h) vitamin C,

i) vitamin D,

j) vitamin E

k) selenium,

l) zinc, and

m) copper,

wherein the oral supplement supports skin health.

2 . The oral supplement according to claim 1 further comprising at least one inactive ingredient.

3 . The oral supplement according to claim 2 , wherein the at least one inactive ingredient is selected from the group consisting of magnesium stearate, silicon dioxide, microcrystalline cellulose, stearic acid, and combinations thereof.

4 . The oral supplement according to claim 1 , wherein the oral supplement is in the form of a powder-filled capsule.

5 . A method of treating skin comprising the step of administering to a subject the oral supplement of claim 1 formulated to support skin health.

6 . The method according to claim 5 , wherein the oral supplement is administered at least once a day.

7 . The method according to claim 5 , wherein the oral supplement is administered in the form of at least one powder-filled capsule.

8 . The method according to claim 5 further comprising at least one inactive ingredient.

9 . The method according to claim 8 , wherein the at least one inactive ingredient is selected from the group consisting of magnesium stearate, silicon dioxide, microcrystalline cellulose, stearic acid, and combinations thereof.

10 . The method according to claim 5 , wherein the subject suffers from a skin condition selected from the group consisting of wrinkles, fine lines, hyperpigmentation, uneven tone, loss of firmness, creepiness, surface roughness, dark circles, under-eye puffiness, crow's feet, visible sun damage, redness, dryness, irritation, skin sagging, skin slackening, enlarged pores and combinations thereof.

11 . The method according to claim 5 , further comprising the step of applying a topical skin care composition to the skin of the subject.

12 . The method according to claim 11 , wherein the topical skin care composition is applied at least once a day.

13 . The method according to claim 12 , wherein the topical skin care composition is applied twice a day.

Assignments (5)
SECURITY INTEREST Recorded Dec 2, 2014
From: ARBONNE INTERNATIONAL, LLC
To: BANK OF AMERICA, N.A., AS COLLATERAL AGENT
Reel/Frame 034311/0950 →
SECURITY AGREEMENT Recorded Jul 3, 2013
From: ARBONNE INTERNATIONAL, LLC
To: BANK OF AMERICA, N.A.
Reel/Frame 030746/0852 →
RELEASE OF SECURITY INTEREST IN INTELLECTUAL PROPERTY COLLATERAL Recorded Jul 2, 2013
From: GENERAL ELECTRIC CAPITAL CORPORATION, AS COLLATERAL AGENT
To: ARBONNE INTERNATIONAL, LLC
Reel/Frame 030746/0178 →
SECURITY AGREEMENT Recorded Nov 16, 2011
From: ARBONNE INTERNATIONAL, LLC
To: GENERAL ELECTRIC CAPITAL CORPORATION, AS COLLATERAL AGENT
Reel/Frame 027241/0497 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 12, 2011
From: MATRAVERS, PETER; HICKS, DEBORAH; WIENER, SHEREE; ARTH, MICHELE
To: ARBONNE INTERNATIONAL LLC
Reel/Frame 026268/0961 →